Citation Impact
Citing Papers
DiffVar: a new method for detecting differential variability with application to methylation in cancer and aging
2014
DNA Hypomethylation and Ovarian Cancer Biology
2004
BRCA1-Associated Epigenetic Regulation of p73 Mediates an Effector Pathway for Chemosensitivity in Ovarian Carcinoma
2010
A possible mechanism for exonuclease 1-independent eukaryotic mismatch repair
2009 StandoutNobel
Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes
2010 StandoutScience
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
2010 StandoutScience
CpG island methylator phenotype in cancer
2004
Saccharomyces cerevisiae MutLα Is a Mismatch Repair Endonuclease
2007 StandoutNobel
Mismatch Repair-dependent Iterative Excision at Irreparable O6-Methylguanine Lesions in Human Nuclear Extracts
2006 StandoutNobel
Human Mismatch Repair
2005 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Mechanisms in Eukaryotic Mismatch Repair
2006 StandoutNobel
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
The DNA-damage response in human biology and disease
2009 StandoutNature
Mismatch repair defects in cancer
2000
Involvement of Members of the Cadherin Superfamily in Cancer
2009
Mismatch repair and DNA damage signalling
2004
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome
2007 StandoutNobel
Molecular mechanisms of drug resistance
2005
Mapping of genetic and epigenetic regulatory networks using microarrays
2005
Imaging in the era of molecular oncology
2008 StandoutNature
The resurgence of platinum-based cancer chemotherapy
2007 Standout
The power and the promise of DNA methylation markers
2003
Interactions of Human Mismatch Repair Proteins MutSα and MutLα with Proteins of the ATR-Chk1 Pathway
2009 StandoutNobel
DNA repair pathways as targets for cancer therapy
2008
The MutSα-Proliferating Cell Nuclear Antigen Interaction in Human DNA Mismatch Repair
2008 StandoutNobel
Hydrolytic function of Exo1 in mammalian mismatch repair
2014 StandoutNobel
A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells
2006 Standout
Recognition and processing of cisplatin- and oxaliplatin-DNA adducts
2004
Endonucleolytic Function of MutLα in Human Mismatch Repair
2006 StandoutNobel
Functional Copy-Number Alterations in Cancer
2008
Mechanisms of therapy-related carcinogenesis
2005
Signalling cell cycle arrest and cell death through the MMR System
2005
Epigenetics in Cancer
2008 Standout
Analysis of the Catalytic Domain of Phosphatidylinositol 4-Kinase Type II
2002 StandoutNobel
Human Exonuclease I Is Required for 5′ and 3′ Mismatch Repair
2002 StandoutNobel
Structures of Human Exonuclease 1 DNA Complexes Suggest a Unified Mechanism for Nuclease Family
2011 StandoutNobel
Cellular processing of platinum anticancer drugs
2005 Standout
Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis
2004
A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression
2011 StandoutNature
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
2004
Genome maintenance mechanisms for preventing cancer
2001 StandoutNature
Reactivating the expression of methylation silenced genes in human cancer
2002
Role of DNA mismatch repair in apoptotic responses to therapeutic agents
2004
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
limma powers differential expression analyses for RNA-sequencing and microarray studies
2015 Standout
MutLα and Proliferating Cell Nuclear Antigen Share Binding Sites on MutSβ
2010 StandoutNobel
The Polycomb group protein EZH2 directly controls DNA methylation
2005 StandoutNature
Features of trinucleotide repeat instability in vivo
2008
Msh2 deficiency does not contribute to cisplatin resistance in mouse embryonic stem cells
2004
Lipid rafts and little caves
2002
Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells
2000
The role of senescent cells in ageing
2014 StandoutNature
Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry
2010
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
2009 Standout
Functions of MutLα, Replication Protein A (RPA), and HMGB1 in 5′-Directed Mismatch Repair
2009 StandoutNobel
Mechanism of 5′-Directed Excision in Human Mismatch Repair
2003 StandoutNobel
DNA methylation and human disease
2005 Standout
The cancer genome
2009 StandoutNature
DNA mismatch repair and acquired cisplatin resistance in E. coli and human ovarian carcinoma cells
2002
Involvement of the β Clamp in Methyl-directed Mismatch Repair in Vitro
2009 StandoutNobel
PCNA function in the activation and strand direction of MutLα endonuclease in mismatch repair
2010 StandoutNobel
SWI/SNF Chromatin-Remodeling Factors Induce Changes in DNA Methylation to Promote Transcriptional Activation
2005
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Telomerase core components protect Candida telomeres from aberrant overhang accumulation
2007 StandoutNobel
Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy.
2000
A gene hypermethylation profile of human cancer.
2001 Standout
Cellular and molecular pharmacology of oxaliplatin.
2002
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
PMS2 endonuclease activity has distinct biological functions and is essential for genome maintenance
2010 StandoutNobel
A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster
2009
Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents
2000
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Exo1 and Rad24 Differentially Regulate Generation of ssDNA at Telomeres of Saccharomyces cerevisiae cdc13-1 Mutants
2004
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
Genome-Wide Views of Chromatin Structure
2009
DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes
2006
Human exonuclease 1 and BLM helicase interact to resect DNA and initiate DNA repair
2008 StandoutNobel
Human DNA Repair Genes
2001 StandoutScienceNobel
Direct Cellular Responses to Platinum-Induced DNA Damage
2007
Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase
2010 StandoutNobel
Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity of Non–Small-Cell Lung Carcinoma Cell Lines and Xenografts to Epidermal Growth Factor Receptor Inhibition
2005
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Works of Gordon Strathdee being referenced
Inactivation of HOXA Genes by Hypermethylation in Myeloid and Lymphoid Malignancy is Frequent and Associated with Poor Prognosis
2007
Epigenetic inactivation ofMCJ (DNAJD1) in malignant paediatric brain tumours
2005
Epigenetic versus genetic alterations in the inactivation of E-cadherin
2002
Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines
1999
Primary Ovarian Carcinomas Display Multiple Methylator Phenotypes Involving Known Tumor Suppressor Genes
2001
A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer
1999
Epigenomics and epigenetic therapy of cancer
2002
A role for mismatch repair in control of DNA ploidy following DNA damage
2001
Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene
2003
HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia
2006
DNA methylation abnormalities at gene promoters are extensive and variable in the elderly and phenocopy cancer cells
2014
Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers.
2002
CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer
2005
Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.
2000